{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:53:10Z","timestamp":1791643990683,"version":"4.3.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"suppl_6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,1]]},"DOI":"10.1093\/jac\/dkr453","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T19:40:29Z","timestamp":1321558829000},"page":"vi3-vi12","source":"Crossref","is-referenced-by-count":87,"title":["European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997\u20132009)"],"prefix":"10.1093","volume":"66","author":[{"name":"on behalf of the ESAC Project Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Adriaenssens","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"},{"name":"Centre for General Practice, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Coenen","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"},{"name":"Centre for General Practice, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Versporten","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Muller","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girma","family":"Minalu","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), University of Hasselt, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Faes","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), University of Hasselt, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Vankerckhoven","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Aerts","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), University of Hasselt, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niel","family":"Hens","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), University of Hasselt, Hasselt, Belgium"},{"name":"Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Molenberghs","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), University of Hasselt, Hasselt, Belgium"},{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,12]]},"reference":[{"key":"key\n\t\t\t\t20180817020352_DKR453C1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2125.2004.02164.x","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach","volume":"58","author":"Vander Stichele","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180817020352_DKR453C2","first-page":"13","article-title":"Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine","volume":"45","author":"Aelvoet","year":"2002","journal-title":"OJ L34"},{"key":"key\n\t\t\t\t20180817020352_DKR453C3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jac\/dkl188","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe","volume":"58","author":"Ferech","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jac\/dkl186","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe","volume":"58","author":"Ferech","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jac\/dkl185","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe","volume":"58","author":"Coenen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/jac\/dkl184","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe","volume":"58","author":"Coenen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/jac\/dkl183","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe","volume":"58","author":"Ferech","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"key\n\t\t\t\t20180817020352_DKR453C8","first-page":"vi13","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997\u20132009)","volume":"66","author":"Versporten","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"key\n\t\t\t\t20180817020352_DKR453C9","first-page":"vi25","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997\u20132009)","volume":"66","author":"Versporten","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"key\n\t\t\t\t20180817020352_DKR453C10","first-page":"vi37","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997\u20132009)","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"key\n\t\t\t\t20180817020352_DKR453C11","doi-asserted-by":"crossref","first-page":"vi47","DOI":"10.1093\/jac\/dkr457","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997\u20132009)","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"key\n\t\t\t\t20180817020352_DKR453C12","doi-asserted-by":"crossref","first-page":"vi71","DOI":"10.1093\/jac\/dkr459","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"key\n\t\t\t\t20180817020352_DKR453C13","first-page":"vi57","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997\u20132009)","volume":"66","author":"Coenen","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"key\n\t\t\t\t20180817020352_DKR453C14","doi-asserted-by":"crossref","first-page":"vi79","DOI":"10.1093\/jac\/dkr460","article-title":"Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis","volume":"66","author":"Minalu","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"key\n\t\t\t\t20180817020352_DKR453C15","doi-asserted-by":"crossref","first-page":"vi89","DOI":"10.1093\/jac\/dkr461","article-title":"Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis","volume":"66","author":"Faes","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C16","volume-title":"Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC Classification and DDD Assignment 2011","author":"WHO Collaborating Centre for Drug Statistics Methodology"},{"key":"key\n\t\t\t\t20180817020352_DKR453C17","volume-title":"European Health For All Database","author":"WHO Regional Office for Europe"},{"key":"key\n\t\t\t\t20180817020352_DKR453C18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)70799-6","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180817020352_DKR453C19","volume-title":"ESAC Yearbook 2009","author":"ESAC Management Team, ESAC Scientific Advisory Board and ESAC National Networks","year":"2011"},{"key":"key\n\t\t\t\t20180817020352_DKR453C20","volume-title":"ESAC Yearbook 2008","author":"ESAC Management Team, ESAC Scientific Advisory Board and ESAC National Networks","year":"2009"},{"key":"key\n\t\t\t\t20180817020352_DKR453C21","volume-title":"ESAC Yearbook 2007","author":"ESAC Management Team, ESAC Scientific Advisory Board and ESAC National Networks","year":"2008"},{"key":"key\n\t\t\t\t20180817020352_DKR453C22","volume-title":"ESAC Yearbook 2006","author":"ESAC Management Team, ESAC Scientific Advisory Board and ESAC National Networks","year":"2007"},{"key":"key\n\t\t\t\t20180817020352_DKR453C23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/qshc.2006.021121","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe","volume":"16","author":"Coenen","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"key\n\t\t\t\t20180817020352_DKR453C24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/jac\/dkh480","article-title":"Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities","volume":"54","author":"Akkerman","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C25","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in children and teenagers in Europe","author":"Versporten"},{"key":"key\n\t\t\t\t20180817020352_DKR453C26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/jac\/dkn386","article-title":"Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis","volume":"62","author":"Davey","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C27","article-title":"Stora regionala skillnader i antibiotikaf\u00f6rbrukningen under 2010. Pressmeddelande fr\u00e5n Smittskyddsinstitutet 2011-01-28"},{"key":"key\n\t\t\t\t20180817020352_DKR453C28","first-page":"96","article-title":"F\u00f6rb\u00e4ttrad antibiotikaanv\u00e4ndning i fokus i regeringens patients\u00e4kerhetssatsning","volume":"108","author":"Tegmark-Wisell","year":"2011","journal-title":"L\u00e4kartidningen"},{"key":"key\n\t\t\t\t20180817020352_DKR453C29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjqs.2010.049049","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing","author":"Adriaenssens","year":"2011","journal-title":"BMJ Qual Saf"},{"key":"key\n\t\t\t\t20180817020352_DKR453C30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jac\/dkl457","article-title":"Is self-medication with antibiotics in Europe driven by prescribed use?","volume":"59","author":"Grigoryan","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jac\/dkn054","article-title":"Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system","volume":"61","author":"Grigoryan","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180817020352_DKR453C32","author":"Nomenclature of Territorial Units for Statistics of the European Commission"},{"key":"key\n\t\t\t\t20180817020352_DKR453C33","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1469-0691.2011.03500.x","article-title":"Secular trends in antibiotic consumption in the adult population in Emilia-Romagna, Italy, 2003\u20132009","volume":"17","author":"Pan","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180817020352_DKR453C34","article-title":"Analysis of sales data (SD) and reimbursement data (RD) on systemic outpatient antibiotic use in Italy in 2000\u20132002","author":"Ferech"},{"key":"key\n\t\t\t\t20180817020352_DKR453C35","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3201\/eid1411.070467","article-title":"Antimicrobial drug use and resistance in Europe","volume":"14","author":"van de Sande-Bruinsma","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180817020352_DKR453C36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijantimicag.2011.02.005","article-title":"Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme","volume":"38","author":"Nathwani","year":"2011","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/66\/suppl_6\/vi3\/25503257\/dkr453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T15:20:16Z","timestamp":1560957616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/66\/suppl_6\/vi3\/679453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,1]]},"references-count":36,"journal-issue":{"issue":"suppl_6","published-online":{"date-parts":[[2011,12]]},"published-print":{"date-parts":[[2011,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkr453","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,12]]},"published":{"date-parts":[[2011,12,1]]}}}